Cellular senescence and senolytics: the path to the clinic
S Chaib, T Tchkonia, JL Kirkland - Nature medicine, 2022 - nature.com
Interlinked and fundamental aging processes appear to be a root-cause contributor to many
disorders and diseases. One such process is cellular senescence, which entails a state of …
disorders and diseases. One such process is cellular senescence, which entails a state of …
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …
Past and future directions for research on cellular senescence
Y Zhu, ZP Anastasiadis… - Cold Spring …, 2024 - perspectivesinmedicine.cshlp.org
Cellular senescence was initially described in the early 1960s by Hayflick and Moorehead.
They noted sustained cell-cycle arrest after repeated subculturing of human primary cells …
They noted sustained cell-cycle arrest after repeated subculturing of human primary cells …
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial
J Hammersen, S Birndt, K Döhner, P Reuken… - Leukemia, 2023 - nature.com
Dysregulated hyperinflammatory response is key in the pathogenesis in patients with severe
COVID-19 leading to acute respiratory distress syndrome and multiorgan failure. Whilst …
COVID-19 leading to acute respiratory distress syndrome and multiorgan failure. Whilst …
Potential convergence of olfactory dysfunction in Parkinson's disease and COVID-19: The role of neuroinflammation
H Li, J Qian, Y Wang, J Wang, X Mi, L Qu… - Ageing Research …, 2024 - Elsevier
Parkinson's disease (PD) is a prevalent neurodegenerative disorder that affects 7-10 million
individuals worldwide. A common early symptom of PD is olfactory dysfunction (OD), and …
individuals worldwide. A common early symptom of PD is olfactory dysfunction (OD), and …
Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via …
S Dissook, S Umsumarng, S Mapoung… - Frontiers in …, 2023 - frontiersin.org
Objective The multi-systemic inflammation as a result of COVID-19 can persevere long after
the initial symptoms of the illness have subsided. These effects are referred to as Long …
the initial symptoms of the illness have subsided. These effects are referred to as Long …
Anti-Inflammatory and Antiatopic Effects of Rorippa cantoniensis (Lour.) Ohwi in RAW 264.7 and HaCaT Cells
MJ Kim, BS Hwang, Y Hwang, YT Jeong, DW Jeong… - Molecules, 2023 - mdpi.com
This study evaluated the effects of Rorippa cantoniensis (Lour.) ohwi extract (RCE) on
factors associated with inflammation-related skin lesions in RAW 264.7 and HaCaT cells …
factors associated with inflammation-related skin lesions in RAW 264.7 and HaCaT cells …
[HTML][HTML] COVID-19 patients with high TNF/IFN-γ levels show hallmarks of PANoptosis, an inflammatory cell death
Y Palacios, LA Ramón-Luing, A Ruiz… - Microbes and …, 2023 - Elsevier
TNF and IFN-γ trigger cell damage during SARS CoV-2 infection; these cytokines can
induce senescence and a cell death process called PANoptosis. This study included 138 …
induce senescence and a cell death process called PANoptosis. This study included 138 …
Single-cell expression atlas reveals cell heterogeneity in the creeping fat of Crohn's disease
W Shu, Y Wang, C Li, L Zhang… - Inflammatory Bowel …, 2023 - academic.oup.com
Abstract Background Creeping fat (CrF) has been recognized to play a positive role in
Crohn's disease (CD) progression, yet the cellular compositions within mesenteric adipose …
Crohn's disease (CD) progression, yet the cellular compositions within mesenteric adipose …
[HTML][HTML] Biomedical generative pre-trained based transformer language model for age-related disease target discovery
Target discovery is crucial for the development of innovative therapeutics and diagnostics.
However, current approaches often face limitations in efficiency, specificity, and scalability …
However, current approaches often face limitations in efficiency, specificity, and scalability …